Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6077516 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1296837 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1296550 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1297108 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1296832 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL22361227 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL11823716 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1297175 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL11833028 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 | |
| SCHEMBL1296595 | 1.00 | NAAA (0.59) | NAAAEPHX1PPARGTSHRCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7208545-B1 | Selected cyclohexane -1,3-and -1,4-dicarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-24 | — | — | US | claimed |
| EP-3228667-B1 | INSULATION MATERIAL | KURARAY CO (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20240352301-A1 | METHANOL-FREE ORGANIC PEROXIDE EMULSION | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-10-24 | — | — | US | disclosed |
| EP-4450527-A1 | METHANOL-FREE ORGANIC PEROXIDE EMULSION | Nouryon Chemicals International B.V. (NL) | 2024-10-23 | — | — | EP | disclosed |
| EP-3747860-B1 | NOVEL CYCLOHEXANONE BASED PLASTICISERS | BASF SE (DE) | 2023-07-26 | — | — | EP | disclosed |
| EP-3392036-B1 | METHOD FOR PRODUCING LAMINATE, AND LAMINATE | KANEKA CORP (JP) | 2022-03-30 | — | — | EP | disclosed |
| US-11059779-B2 | Storage stable aqueous organic peroxide emulsions | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-07-13 | — | — | US | disclosed |
| US-10811165-B2 | Insulation material | KURARAY CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| CN-107001805-B | Insulating material | 株式会社可乐丽 | 2020-10-02 | — | — | CN | disclosed |
| EP-3115419-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20110291040-A1 | PROCESS FOR PRODUCING EXPANDABLE STYRENE POLYMER COMPOSITIONS | BASF SE (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110265693-A1 | Use Of Polyols And Cyclohexane Polycarboxylic Acid Derivatives For The Removal Of Dust From Chemical Construction Products | Construction Research & Tecnology GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110232825-A1 | CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
| US-20100174018-A1 | AQUEOUS FORMULATIONS AND THE USE THEREOF FOR COLORING OR COATING SUBSTRATES | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| US-7337913-B2 | Single piece closure device made of PVC | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-04 | — | — | US | disclosed |
| US-7208545-B1 | Selected cyclohexane -1,3-and -1,4-dicarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-24 | — | — | US | disclosed |
| US-20050106405-A1 | Single piece closure device made of pvc | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | US | disclosed |
| US-6683030-B2 | CONTAINING A CYCLOHEXANEPOLYCARBOXYLIC ACID ESTER, ESPECIALLY A DIISOALKYL 1,2-CYCLOHEXANEDICARBOXYLATE; A NONIONIC SURFACTANT; WATER; AND AN ACTIVE PLANT TREATMENT AGENT, E.G, HERBICIDE OR PLANT GROWTH REGULATOR | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |
| US-20030069135-A1 | Agrotechnical formulation | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069135-A1 | Agrotechnical formulation | HACL2, CBR1, ACACA | NAAA 819/4885EPHX1 1168/4885PPARG 688/4885 |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HPD, HCAR2 | NAAA 1278/4885EPHX1 1120/4885PPARG 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.